Constipation-predominant Irritable Bowel Syndrome Clinical Trial
Official title:
Anorectal Manometry of Patients With Constipation Predominant Irritable Bowel Syndrome
The aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome
Chronic constipation (CC) is a common medical problem throughout the world [1-3] The global prevalence of CC in the community varies from 11% to 18% [4]. In patients presenting to tertiary care facilities, specific pathophysiological abnormalities like defecatory disorder and slow colonic transit contribute to CC. CC has a significant burden on the utilization of healthcare resources, including the cost of inpatient and outpatient care, laboratory tests, and diagnostic procedures [5, 6]. CC is characterized by difficulty in passing stools or a low frequency of bowel movements, often accompanied by straining during defecation or a feeling of incomplete evacuation [7, 8]. For western population, CC is defined by Bristol stool form (BSF) I-II, while in Indian patients, addition of type III Bristol stool form increases diagnostic sensitivity [2]. In the ROME IV criteria, it has been suggested that all patients with CC without evidence of structural or metabolic abnormalities to explain symptoms should be considered under the umbrella of functional constipation (FC) [8]. FC is defined as the presence of two or more of the followings during the previous 3 months: 1. Defecatory straining (> 25% of bowel movements) 2. Hard or lumpy stools (> 25% of bowel movements) 3. Feeling of incomplete evacuation (> 25% of bowel movements) 4. Defecatory obstruction (> 25% of bowel movements) 5. Manual maneuvers to facilitate defecation (> 25% of bowel movements) 6. Fewer than three spontaneous complete bowel movements per week. Symptoms must be present for at least 6 months before the diagnosis, and diarrhea must not be present except after using a laxative [8]. Patients with FC should not meet irritable bowel syndrome (IBS) criteria, although bloating may be present. In contrast, patients with irritable bowel syndrome with constipation (IBS-C) have abdominal pain as the predominant symptom along with Bristol stool form types 1 or 2 more than 25% of the times. [8]. Among patients presenting with CC, Indian studies have reported FC to be commoner than IBS-C [9, 10-12]. High-resolution (HR-) anorectal manometry has significant diagnostic value in the assessment of anorectal disorders [13] This study aimed to compare the clinical and anorectal manometry profile of patients with FC and constipation-predominant irritable bowel syndrome ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00742872 -
Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
|
Phase 3 | |
Completed |
NCT05164861 -
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations
|
N/A | |
Withdrawn |
NCT05321953 -
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
|
N/A | |
Not yet recruiting |
NCT06319729 -
A Chinese Herbal Medicine for IBS-C
|
Phase 2 | |
Completed |
NCT01085643 -
Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
|
N/A | |
Completed |
NCT03150212 -
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype
|
N/A | |
Recruiting |
NCT05757037 -
Laser Acupuncture on Irritable Bowel Syndrome in Females
|
N/A | |
Completed |
NCT05392439 -
Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome
|
N/A | |
Recruiting |
NCT05134584 -
Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
|
Phase 4 | |
Terminated |
NCT03336034 -
Assessment of Responsiveness to Treatment by Experience Sampling Method
|
||
Not yet recruiting |
NCT04666155 -
MOWOOT Device Treatment for Adults With Chronic Constipation
|
N/A | |
Not yet recruiting |
NCT05941650 -
To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT00945334 -
Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT00912301 -
Cheno Effect on Transit in Health and IBS-C
|
Phase 2 | |
Terminated |
NCT00607971 -
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
|
Phase 3 |